Medical Daily media bias and reliability
Ad Fontes Media places Medical Daily in the centre. We have seen it on 16 published stories of ours.
The short answers
Is Medical Daily biased?
Ad Fontes Media places Medical Daily in the centre. An outlet rating describes a broad pattern in its output, not every article it publishes.
Is Medical Daily left or right?
Ad Fontes Media places Medical Daily in the centre. In the three-way grouping used on story pages, that puts it under Centre.
Is Medical Daily reliable?
The factual-reliability assessments we hold for Medical Daily are Ad Fontes Media: Very high factuality; Media Bias/Fact Check: Mixed factuality. These are outlet-level assessments, not a guarantee that every report is correct.
What Medical Daily has been covering
Our account of each story, written from every outlet that ran it, with Medical Daily’s own report linked underneath.
Health and Human Services Secretary Robert F. Kennedy Jr. delivered a keynote address at a conference for the anti-vaccine group Children's Health Defense, which he formerly chaired. He told attendees they had a friend in the Trump White House and highlighted administration actions to alter vaccine guidance.
Medical Daily reported it asKennedy Set to Keynote Children's Health Defense Conference Thursday, Returning to the Anti-Vaccine Group He Once Led (opens Medical Daily in a new tab)
Drinking very hot beverages, defined as 65C or above, triples the risk of oesophageal cancer compared to warm drinks, according to a large Oxford University study. Consuming six or more hot drinks a day also increases the risk, though the overall likelihood of developing the cancer remains low.
Medical Daily reported it asVery Hot Tea and Coffee Linked to Triple the Risk of One Esophageal Cancer Type in Britain (opens Medical Daily in a new tab)
Insilico Medicine's AI-designed drug rentosertib, tested in a small study for idiopathic pulmonary fibrosis, indicated a reduction in biological age markers. Six independent aging clocks suggested patients treated with the drug appeared biologically younger than those on placebo, with the largest effect seen in the 30mg twice-daily arm.
Medical Daily reported it asSix Aging Clocks Said This AI-Designed Lung Drug Lowered Biological Age, and the Smaller Dose Won (opens Medical Daily in a new tab)
A study examining UK medical records found that semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a nearly 40% reduction in asthma attacks and a 20% decrease in COPD flare-ups. Scientists suggest anti-inflammatory properties may be responsible, but caution that further trials are needed.
Medical Daily reported it asSemaglutide Users with Asthma Had Nearly 40 Percent Fewer Attacks in UK Records but Doctors Urge Caution (opens Medical Daily in a new tab)
The Centers for Disease Control and Prevention has excluded two measles-associated deaths reported by Pennsylvania from its latest weekly update. The agency stated the decision was made pending further investigation into the cause of the deaths.
Medical Daily reported it asSix-Week-Old Infant Confirmed to Have Died of Measles as U.S. Cases Reach 3,134 (opens Medical Daily in a new tab)
Lianyong Wei, 51, died in ICE custody in the Northern Mariana Islands on Aug. 23. He had been arrested two days earlier on assault charges and taken into ICE custody pending removal. China's Consulate General in Los Angeles has demanded a thorough investigation.
Medical Daily reported it asA Man Died Within a Day of Entering ICE Custody and Nobody Will Say If He Was Screened (opens Medical Daily in a new tab)
The US Department of Defense issued mandatory testosterone deficiency screening guidelines for active-duty and reserve service members aged 30 and older. Men will undergo blood tests, while women will be screened for fatigue and menstrual cycle disruptions. Treatment remains optional.
Medical Daily reported it asPentagon Requires Testosterone Testing for Male Troops Age 30 and Older Ahead of an FDA Expert Meeting (opens Medical Daily in a new tab)
A federal judge has paused a lawsuit aiming to overturn the FDA's approval of the abortion pill mifepristone. The case will not proceed until at least December 1, following a request from the Department of Justice.
Medical Daily reported it asAbortion Pill Case Is Frozen Until December While a Federal Judge Waits for the FDA Review (opens Medical Daily in a new tab)
Higher levels of the popular sugar substitute xylitol have been associated with a significantly greater risk of heart attack and stroke, according to new research. The analysis examined data from over 17,000 individuals, finding those with xylitol in their blood were at increased risk of major cardiovascular events.
Medical Daily reported it asPeople with the Most of This Sugar Substitute in Their Blood Had More Heart Attacks and Strokes (opens Medical Daily in a new tab)
The Centers for Disease Control and Prevention has excluded two measles-associated deaths reported by Pennsylvania from its latest weekly update. The agency stated the decision was made pending further investigation into the cause of the deaths.
Medical Daily reported it asThe CDC Posted Its Delayed Measles Update at 2,903 Cases and Left Two Pennsylvania Deaths Uncounted (opens Medical Daily in a new tab)
Lancaster County Commissioner Joshua Parsons accused Governor Josh Shapiro of deception regarding two measles-associated deaths. The county coroner stated the infant died from a ruptured spleen, not measles. The state has confirmed 460 measles cases.
Medical Daily reported it asPennsylvania Measles Outbreak Reaches 460 Cases and Two Western Counties as Officials Publicly Disagree Over Deaths (opens Medical Daily in a new tab)
Research indicates the Shingrix vaccine may provide protection against cardiovascular events and dementia. A study found a reduced risk of heart disease and cognitive decline in those vaccinated compared to an older vaccine.
Medical Daily reported it asShingles Vaccine Linked to 24% Lower Dementia Risk in More Than 500,000 Older Adults, Study Finds (opens Medical Daily in a new tab)
The U.S. Food and Drug Administration has approved daraxonrasib, branded as Rasonque, for metastatic pancreatic cancer. In trials, patients taking the drug lived a median of 13.2 months, compared to 6.7 months on chemotherapy.
Medical Daily reported it asPancreatic Cancer Patients No Longer Need Expanded Access to Get a RAS Inhibitor After Federal Approval (opens Medical Daily in a new tab)
The U.S. Food and Drug Administration has approved daraxonrasib, branded as Rasonque, for metastatic pancreatic cancer. In trials, patients taking the drug lived a median of 13.2 months, compared to 6.7 months on chemotherapy.
Medical Daily reported it asA Once-Daily Pill for Pancreatic Cancer Just Won Approval, and It Nearly Doubled Survival in Trial (opens Medical Daily in a new tab)
Eight South Koreans working on a hydropower plant project are missing and 10 others are stranded after a flash flood in Nepal. South Korea's Foreign Ministry has established a task force and plans to send a response team to the affected Rasuwa district.
Medical Daily reported it asNepal Flash Flood Kills at Least 95 and Leaves Hundreds Missing as Wrecked Roads Slow Medical Rescue (opens Medical Daily in a new tab)
A 24-year-old Nepali labourer survived a flash flood by clinging to a mango tree after being swept away by a torrent of mud and rock. The disaster has killed at least 150 people and left hundreds missing in Nepal.
Medical Daily reported it asNepal Flash Flood Kills at Least 95 and Leaves Hundreds Missing as Wrecked Roads Slow Medical Rescue (opens Medical Daily in a new tab)
Scientists at the Arc Institute in California used an AI model named Evo to design 16 new bacteriophages capable of infecting E. coli. The study, published in Science, excluded human pathogen datasets, ensuring the viruses cannot infect people. Experts warn of biosecurity risks despite potential medical applications.
Medical Daily reported it asResearchers Used AI to Design Working Viruses, Raising Both Medical Hopes and Biosecurity Concerns (opens Medical Daily in a new tab)
The US Senate passed a bill on 3 August 2026 that includes a one-month delay on federal regulation of intoxicating hemp-derived THC products in Minnesota. The reprieve, part of a short-term funding measure, could be extended beyond December and prevents an immediate ban on the state's hemp-based edibles and drinks industry.
Medical Daily reported it asHemp THC Drinks and Gummies Could Get a One Month Reprieve, but Not for Every Product (opens Medical Daily in a new tab)
Who says so
One organisation has published a rating for this outlet. Where they disagree, the disagreement is the useful part and it is left standing.
- Ad Fontes MediacenterCheck it
How reliably it reports fact
A rating of the newsroom in general, by others, and a different thing from the Trust score we publish on each story, which judges one piece of reporting.
High factuality
Who owns it
We hold no ownership record for Medical Daily.
Where it publishes from
- Official site
- medicaldaily.com
- Seen publishing on
- medicaldaily.com
- Access
- Free to read
- Wikipedia
- Entry
What we have seen ourselves
Counted across the stories this site has published, which is the only denominator a reader can check: every one of them has a page, and every page lists the reports it was written from.
- Stories
- 16
- Reports listed
- 18
- We could read
- 0
- First seen
- 4 August 2026
18 of those reports were paywalled or blocked to us. Our reading of this outlet is built on the 0 we could open, not on everything it published.
A blindspot is measured against one side of the spectrum. Medical Daily is rated centre, so there is no side for it to be counted against and we publish no figure here.
Across the 16 stories of ours where at least three of the reports we listed carried a time, we logged no report earlier than Medical Daily’s on 2 of them. Overall it filed a median of 24 hours after the earliest report we logged.
Measured 20 September 2026. Last seen in a coverage list 19 September 2026. Ratings pulled 5 September 2026.
Other outlets rated the same way
Publishers carrying the same published leaning as Medical Daily, ordered by how often we have seen them on a story. Sharing a rating is not the same as being alike.
Think this page is wrong?
The leanings above are published by AllSides, Ad Fontes Media and Media Bias/Fact Check, and we republish them rather than make them. If you think one is misapplied, the strongest place to say so is with the organisation that made it, and every verdict here links to their page.
What we are responsible for is everything else: the ownership chain, where Medical Daily publishes from, which of our stories we have listed it on, and whether we have the right publisher at all. Tell us what is wrong and an editor reads it.
Report something wrong on this page
Anything we correct is written up in the public corrections log. We do not publish reader votes as a rating, because an unattributed rating is the thing this site exists to argue against.
Every rating on this page is a named third party’s published work, republished with its author and, where one exists, a link to it. Our own coverage record is the section we measure ourselves. Neither is a judgement of any individual report: those are scored story by story, and the reasoning is on our methodology page.